Medicamen Biotech Statistics

Total Valuation

NSE:MEDICAMEQ has a market cap or net worth of INR 4.25 billion. The enterprise value is 4.20 billion.

Market Cap	4.25B
Enterprise Value	4.20B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

Current Share Class	12.71M
Shares Outstanding	n/a
Shares Change (YoY)	+9.75%
Shares Change (QoQ)	+5.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.85M

Valuation Ratios

The trailing PE ratio is 54.68.

PE Ratio	54.68
Forward PE	n/a
PS Ratio	2.47
PB Ratio	1.54
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	54.03
EV / Sales	2.44
EV / EBITDA	22.27
EV / EBIT	35.15
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.14
Debt / EBITDA	2.05
Debt / FCF	n/a
Interest Coverage	3.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	3.38%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.82%
Revenue Per Employee	4.58M
Profits Per Employee	206,535
Employee Count	376
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:MEDICAMEQ has paid 22.02 million in taxes.

Income Tax	22.02M
Effective Tax Rate	23.39%

Stock Price Statistics

The stock price has decreased by -26.41% in the last 52 weeks. The beta is 0.46, so NSE:MEDICAMEQ's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-26.41%
50-Day Moving Average	369.44
200-Day Moving Average	378.21
Relative Strength Index (RSI)	39.83
Average Volume (20 Days)	19,505

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDICAMEQ had revenue of INR 1.72 billion and earned 77.66 million in profits. Earnings per share was 5.84.

Revenue	1.72B
Gross Profit	868.89M
Operating Income	119.36M
Pretax Income	94.15M
Net Income	77.66M
EBITDA	188.39M
EBIT	119.36M
Earnings Per Share (EPS)	5.84

Full Income Statement

Balance Sheet

The company has 436.79 million in cash and 386.49 million in debt, with a net cash position of 50.31 million.

Cash & Cash Equivalents	436.79M
Total Debt	386.49M
Net Cash	50.31M
Net Cash Per Share	n/a
Equity (Book Value)	2.75B
Book Value Per Share	161.11
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 50.49%, with operating and profit margins of 6.94% and 4.51%.

Gross Margin	50.49%
Operating Margin	6.94%
Pretax Margin	5.47%
Profit Margin	4.51%
EBITDA Margin	10.95%
EBIT Margin	6.94%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.29%.

Dividend Per Share	1.00
Dividend Yield	0.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.75%
Shareholder Yield	-9.45%
Earnings Yield	1.83%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2